The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Blocking LILRB and KIR receptors by B57 open conformers induces potent antitumor activity and acts synergistically with checkpoint blockade inhibition.
 
Christoph Renner
Stock and Other Ownership Interests - Agios; Array BioPharma; ImmunOs Therapeutics; Infinity Pharmaceuticals; Loxo
Honoraria - Amgen; Celgene; Janssen Biotech; Roche Pharma AG; Takeda
Consulting or Advisory Role - Celgene; Gilead Sciences; ImmunOs Therapeutics; Janssen
Patents, Royalties, Other Intellectual Property - Immunes Therapeutics
Travel, Accommodations, Expenses - Amgen; Celgene; Gilead Sciences; Janssen; Roche
 
Michael A. Curran
Stock and Other Ownership Interests - Aduro Biotech; CytomX Therapeutics; Molecular Templates
Honoraria - Amgen
Consulting or Advisory Role - Agenus; Aptevo Therapeutics; ImmunOs Therapeutics; Mabimmune; Nurix; Peiris Consulting
Research Funding - Immunome (Inst); Molecular Templates
Patents, Royalties, Other Intellectual Property - CTLA-4 Antibody Patent (UC Regents)
 
Julia Kolibaba
Employment - ImmunOs Therapeutics
 
Yang Liu
No Relationships to Disclose
 
Ulf Petrausch
Consulting or Advisory Role - ImmunOs Therapeutics
Patents, Royalties, Other Intellectual Property - ImmunOs Therapeutics
 
Alfred Zippelius
No Relationships to Disclose
 
Frank Stenner
Employment - Cureab (I)
Leadership - Cureab (I)
Stock and Other Ownership Interests - Cureab (I)
Honoraria - roche
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen-Cilag; Roche; Sanofi
Research Funding - Cureab
Patents, Royalties, Other Intellectual Property - Cureab; cureab (I)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Roche; Sanofi
 
Anahita Rafiei
Employment - ImmunOs Therapeutics
 
Osiris Marroquin Belaunzaran
Employment - ImmunOs Therapeutics
Leadership - ImmunOs Therapeutics
Stock and Other Ownership Interests - ImmunOs Therapeutics
Patents, Royalties, Other Intellectual Property - ImmunOs Therapeutics